HALO
Halozyme Therapeutics Inc
Price:  
48.20 
USD
Volume:  
720,188.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HALO Stock Forecast & Price Target

HALO Stock Price Forecast

The average stock forecast for Halozyme Therapeutics Inc (HALO) in the next 12 months is 63.69 USD. This price target corresponds to an upside of 32.14%. The range of stock forecasts for HALO is 50.50 - 78.75 USD. Based on the ratings of 16 analysts, the consensus recommendation for HALO is BUY.
Target Low Average Median High
Price (USD) 50.50 63.69 63.24 78.75
Upside 4.77% 32.14% 31.20% 63.38%

Recommendation Trends

The latest consensus rating for HALO is "BUY". This is the average recommendation of 16 analysts: 0 strong sell, 0 sell, 6 hold, 8 buy, 2 strong buy. In the previous period, 17 analysts also majorly recommmended "BUY" for HALO.

HALO Financial Stock Forecast

Revenue This Year
1,003.37M
21.00%
from 829.25M
Revenue Next Year
1,154.66M
15.08%
from 1,003.37M
EPS This Year
4.28
93.29%
from 2.21
EPS Next Year
4.98
16.44%
from 4.28